Physician profile
Jagdeep Bijwadia
NPI 1861468639
$53,799.47
in general payments reported to CMS, 2019-2025
7 companies · $6,246 in 2025
The $6,246 reported for 2025 was more than what 90% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,009 · 2021: $310 · 2022: $46K · 2023: $139 · 2024: $352 · 2025: $6,246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,832 · Food and Beverage: $905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,832.23 |
| Food and Beverage | $904.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Resmed Corp | $51,392.58 | 2022-2025 | |
| Inspire Medical Systems, INC. | $1,346.26 | 2020-2025 | Inspire |
| Itamar Medical INC | $715.90 | 2022-2025 | Watchpatone |
| Harmony Biosciences LLC | $179.21 | 2024 | |
| Respire Medical Holdings LLC | $116.86 | 2022 | |
| Philips North America LLC | $32.40 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $16.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jagdeep Bijwadia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.